Literature DB >> 18800015

Proteomics of human neurodegenerative diseases.

Jing Zhang1, C Dirk Keene, Catherine Pan, Kathleen S Montine, Thomas J Montine.   

Abstract

The technology, experimental approaches, and bioinformatics that support proteomic research are evolving rapidly. The application of these new capabilities to the study of neurodegenerative diseases is providing insight into the biochemical pathogenesis of neurodegeneration as well as fueling major efforts in biomarker discovery. Here, we review the fundamentals of commonly used proteomic approaches and the outcomes of these investigations with autopsy and cerebrospinal fluid samples from patients with neurodegenerative diseases.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18800015      PMCID： PMC2710115          DOI： 10.1097/NEN.0b013e318187a832

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


  99 in total

Review 1.  Ageing choroid plexus-cerebrospinal fluid system.

Authors:  J E Preston
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

Review 2.  Reproducibility in protein profiling by MALDI-TOF mass spectrometry.

Authors:  Jakob Albrethsen
Journal:  Clin Chem       Date:  2007-03-29       Impact factor: 8.327

3.  Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies.

Authors:  Judit Oláh; Natália Tokési; Orsolya Vincze; István Horváth; Attila Lehotzky; Anna Erdei; Emília Szájli; Katalin F Medzihradszky; Ferenc Orosz; Gábor G Kovács; Judit Ovádi
Journal:  FEBS Lett       Date:  2006-09-27       Impact factor: 4.124

4.  Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Authors:  Annika Olsson; Hugo Vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

6.  CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

Authors:  Jing Zhang; Izabela Sokal; Elaine R Peskind; Joseph F Quinn; Joseph Jankovic; Christopher Kenney; Kathryn A Chung; Steven P Millard; John G Nutt; Thomas J Montine
Journal:  Am J Clin Pathol       Date:  2008-04       Impact factor: 2.493

7.  Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry.

Authors:  Giuseppina Maccarrone; Dale Milfay; Isabel Birg; Marcus Rosenhagen; Florian Holsboer; Rudolf Grimm; Jerome Bailey; Nina Zolotarjova; Christoph W Turck
Journal:  Electrophoresis       Date:  2004-07       Impact factor: 3.535

8.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

Review 9.  Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics.

Authors:  D Allan Butterfield; Rukhsana Sultana
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

Review 10.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Authors:  Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472
View more
  12 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.

Authors:  Natalia Tiberti; Alexandre Hainard; Veerle Lejon; Xavier Robin; Dieudonné Mumba Ngoyi; Natacha Turck; Enock Matovu; John Enyaru; Joseph Mathu Ndung'u; Alexander Scherl; Loïc Dayon; Jean-Charles Sanchez
Journal:  Mol Cell Proteomics       Date:  2010-08-19       Impact factor: 5.911

3.  Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.

Authors:  Waqas Tahir; Saima Zafar; Franc Llorens; Amandeep Singh Arora; Katrin Thüne; Matthias Schmitz; Nadine Gotzmann; Niels Kruse; Brit Mollenhauer; Juan Maria Torres; Olivier Andréoletti; Isidre Ferrer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

4.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

5.  Post-translational Modification in Muscular Dystrophies.

Authors:  Martina Sandonà; Valentina Saccone
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 6.  Proteomics of protein post-translational modifications implicated in neurodegeneration.

Authors:  Ru-Jing Ren; Eric B Dammer; Gang Wang; Nicholas T Seyfried; Allan I Levey
Journal:  Transl Neurodegener       Date:  2014-10-30       Impact factor: 8.014

7.  Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.

Authors:  Joseph O Ojo; Jon M Reed; Gogce Crynen; Prashanthi Vallabhaneni; James Evans; Benjamin Shackleton; Maximillian Eisenbaum; Charis Ringland; Anastasia Edsell; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Front Aging Neurosci       Date:  2021-05-17       Impact factor: 5.750

8.  A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.

Authors:  Sausan Azzam; Laurie Broadwater; Shuo Li; Ernest J Freeman; Jennifer McDonough; Roger B Gregory
Journal:  Proteome Sci       Date:  2013-05-01       Impact factor: 2.480

9.  High blood pressure effects on the blood to cerebrospinal fluid barrier and cerebrospinal fluid protein composition: a two-dimensional electrophoresis study in spontaneously hypertensive rats.

Authors:  Ibrahim González-Marrero; Leandro Castañeyra-Ruiz; Juan M González-Toledo; Agustín Castañeyra-Ruiz; Hector de Paz-Carmona; Rafael Castro; Juan R Hernandez-Fernaud; Agustín Castañeyra-Perdomo; Emilia M Carmona-Calero
Journal:  Int J Hypertens       Date:  2013-01-21       Impact factor: 2.420

Review 10.  Liposomes and nanotechnology in drug development: focus on neurological targets.

Authors:  Pedro Ramos-Cabrer; Francisco Campos
Journal:  Int J Nanomedicine       Date:  2013-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.